Jubilant Ingrevia
- Market cap
- ₹ 9,649 Cr.
- P/E
- 26.3x
- P/B
- 3.07x
- 52-week range
- 537.3 – 795
- ROE
- 10%
- ROCE
- 11%
- Dividend yield
- 0.8%
- Debt / equity
- 0.25
- Sector
- Chemicals & Petrochemicals
- Industry
- Specialty Chemicals
- Listed on
- NSE, BSE
About
Jubilant Ingrevia Limited is a globally integrated life sciences and specialty chemicals company. Its segments include Specialty Chemicals, Nutrition & Health Solutions and Chemical Intermediates. The Specialty chemicals segment includes bio-pyridine & bio-picolines, fine chemicals, agro chemicals, custom development and manufacturing organization, and Microbial control solutions. The Nutrition & Health solutions segment includes nutrition and health ingredients and animal and human nutrition health solutions. The Chemical intermediates segment includes Acetyls and Specialty ethanol. In agro chemicals, it offers value-added derivatives, derived from specialty building blocks, such as amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines and so on. This sub-segment includes insecticides, herbicides and fungicides. In nutrition and health ingredients, it offers products like Vitamin B3 & Picolinates (Chromium & Zinc) which are fully backward integrated.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Specialty Chemicals: 130 companies →Jubilant Ingrevia against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)26.3 against a typical 25.8: pricier than most peers (1st = cheapest).66th of 129
- Sales growth+25.2% against a typical +25.9% from a year earlier.58th of 112
- Profit growth+41.3% against a typical +42.4% from a year earlier.53rd of 102
- Share price, 3 months−20.2% against a typical −5.8%.106th of 118
- Size₹ 9,648.7 Cr. market value against a typical ₹ 359.6 Cr. (1st = largest).14th of 126
Latest announcements
Exchange filings and their impact on the company.
- HR head Vinita Koul resigns effective 6 Nov 2026; no business impact expected.
Jubilant Ingrevia said Ms. Vinita Koul, Sr. Vice President & Head HR, has resigned to pursue other interests, effective close of business on November 06, 2026. The company disclosed the resignation under Regulation 30 with no successor named yet. The change is limited to the HR function and is not expected to affect business operations or financials.
- Board approved Q2 and H1 FY27 results, keeping the recent sales and margin recovery on track.
Jubilant Ingrevia's board on October 27, 2026 approved the unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The meeting ran from 11:10 a.m. to 2:00 p.m. and the results with limited review report were taken on record. The filing confirms the Q2 earnings update, which follows a strong Q1 with higher sales and margins.
- Wholly-owned subsidiary Jubilant Advanced Electronics incorporated, with no immediate financial impact disclosed.
Jubilant Ingrevia has incorporated its wholly-owned subsidiary, Jubilant Advanced Electronics Limited, on October 12, 2026 after approval from the Registrar of Companies. The filing follows its October 1, 2026 intimation about the proposed subsidiary and states all other particulars remain unchanged. No investment amount, capital or business plan was disclosed, so there is no immediate financial impact.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
No up-to-date rating
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CRISIL | — | — | 11 Aug 2026 |
| India Ratings | Withdrawn | Stable | 2 Dec 2025 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 11 Aug 2026 | Reaffirmed | — | — | CRISIL | ₹ 600 Cr. | |
| 2 Dec 2025 | Withdrawn | was IND AA+ | — | India Ratings | ₹ 2,788.38 Cr. | |
| 12 Aug 2025 | Reaffirmed | — | — | CRISIL | ₹ 600 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 27 Oct 2026 | Financial Results | To consider and approve the financial results for the period ended September 30, 2026 |
| 22 Jul 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 26 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 4 Feb 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2025 and dividend |
| 27 Oct 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 31 Jul 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,020 | 966 | 1,074 | 1,024 | 1,045 | 1,057 | 1,051 | 1,038 | 1,121 | 1,051 | 1,179 | 1,300 |
| Expenses | 902 | 871 | 983 | 915 | 921 | 918 | 905 | 896 | 985 | 924 | 1,016 | 1,101 |
| Operating Profit | 118 | 96 | 91 | 110 | 124 | 138 | 147 | 142 | 135 | 126 | 163 | 199 |
| OPM % | 12% | 10% | 8% | 11% | 12% | 13% | 14% | 14% | 12% | 12% | 14% | 15% |
| Other Income | 9 | 9 | 10 | 10 | 10 | 9 | 8 | 11 | 11 | −4 | 9 | 10 |
| Interest | 13 | 15 | 14 | 14 | 15 | 12 | 14 | 13 | 12 | 12 | 12 | 17 |
| Depreciation | 34 | 34 | 36 | 39 | 40 | 40 | 39 | 41 | 41 | 45 | 48 | 51 |
| Profit before tax | 80 | 55 | 51 | 66 | 80 | 96 | 102 | 100 | 93 | 65 | 112 | 141 |
| Tax % | 28% | 30% | 43% | 26% | 26% | 27% | 27% | 25% | 25% | 28% | 23% | 25% |
| Net Profit | 57 | 39 | 29 | 49 | 59 | 69 | 74 | 75 | 69 | 47 | 86 | 106 |
| EPS in Rs | 3.61 | 2.42 | 1.84 | 3.06 | 3.7 | 4.36 | 4.65 | 4.71 | 4.36 | 2.94 | 5.43 | 6.64 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 45%
- 3 Years
- −3%
- TTM
- 11%
- 10 Years
- —
- 5 Years
- 35%
- 3 Years
- −2%
- TTM
- 15%
- 10 Years
- —
- 5 Years
- 1%
- 3 Years
- 18%
- TTM
- —
- 10 Years
- —
- 5 Years
- 11%
- 3 Years
- 8%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Jubilant Ingrevia | ₹ 589.00 | ₹ 9,649 Cr. | 26.3x | 3.1x | 10% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 58.1x | 12.1x | 21.2% | 12.4% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 99.6x | 26.6x | 31.4% | 17.7% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 23.8% | 16.9% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 44.6x | 6.1x | 13.8% | 11.6% |
| Linde India | ₹ 5,697.00 | ₹ 48,586 Cr. | 110.5x | 14.2x | 13.6% | 21.7% |
Management
- Hari Shanker Bhartia
- Executive Co-Chairman of the Board
- Varun Gupta
- President, Chief Financial Officer
- Deepak Jain
- Chief Executive Officer, Managing Director, Executive Director
- Vijay Kumar Srivastava
- Chief of Operations, Whole-Time Director
- Vinita Koul
- Senior Vice President, Head - Human Resources
- Deepanjali Gulati
- Compliance Officer, Company Secretary
Prices are delayed and for information only. Nothing on this page is investment advice.